1. Home
  2. Labeler Index
  3. Inventia Healthcare Limited
  4. 49252-034
  5. NDC Package Code: 49252-034-10 Paliperidone

NDC Package 49252-034-10 Paliperidone

View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
49252-034-10
Package Description:
30 TABLET, EXTENDED RELEASE in 1 BOTTLE
Product Code:
49252-034
Proprietary Name:
Paliperidone
Usage Information:
Paliperidone extended-release tablets are indicated for the treatment of schizophrenia [see Clinical Studies (14.1)]. The efficacy of paliperidone in schizophrenia was established in three 6-week trials in adults and one 6-week trial in adolescents, as well as one maintenance trial in adults.
11-Digit NDC Billing Format:
49252003410
NDC to RxNorm Crosswalk:
  • RxCUI: 672567 - paliperidone 3 MG 24HR Extended Release Oral Tablet
  • RxCUI: 672567 - 24 HR paliperidone 3 MG Extended Release Oral Tablet
  • RxCUI: 672567 - paliperidone 3 MG 24 HR Extended Release Oral Tablet
  • RxCUI: 672569 - paliperidone 6 MG 24HR Extended Release Oral Tablet
  • RxCUI: 672569 - 24 HR paliperidone 6 MG Extended Release Oral Tablet
    • Labeler Name:
    Inventia Healthcare Limited
    Sample Package:
    No
    Start Marketing Date:
    09-01-2019
    Listing Expiration Date:
    12-31-2020
    Exclude Flag:
    I
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 49252-034-10?

    The NDC Packaged Code 49252-034-10 is assigned to a package of 30 tablet, extended release in 1 bottle of Paliperidone, labeled by Inventia Healthcare Limited. The product's dosage form is and is administered via form.

    Is NDC 49252-034 included in the NDC Directory?

    No, Paliperidone with product code 49252-034 is excluded from the NDC Directory because it's listing has been INACTIVATED by FDA. The product was first marketed by Inventia Healthcare Limited on September 01, 2019 and its listing in the NDC Directory is set to expire on December 31, 2020 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 49252-034-10?

    The 11-digit format is 49252003410. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-249252-034-105-4-249252-0034-10